EQUASENS (EQS.PA) Stock Fundamental Analysis
EPA:EQS - Euronext Paris - Matif - FR0012882389 - Common Stock - Currency: EUR
Taking everything into account, EQS scores 6 out of 10 in our fundamental rating. EQS was compared to 11 industry peers in the Health Care Technology industry. EQS scores excellent points on both the profitability and health parts. This is a solid base for a good stock. EQS has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
EQS had positive earnings in the past year.
EQS had a positive operating cash flow in the past year.
Each year in the past 5 years EQS has been profitable.
EQS had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
With an excellent Return On Assets value of 9.10%, EQS belongs to the best of the industry, outperforming 81.82% of the companies in the same industry.
EQS's Return On Equity of 15.65% is amongst the best of the industry. EQS outperforms 90.91% of its industry peers.
EQS has a Return On Invested Capital of 12.02%. This is amongst the best in the industry. EQS outperforms 90.91% of its industry peers.
The Average Return On Invested Capital over the past 3 years for EQS is significantly above the industry average of 7.26%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 9.1% | ||
| ROE | 15.65% | ||
| ROIC | 12.02% |
ROA(3y)11.42%
ROA(5y)11.3%
ROE(3y)20.52%
ROE(5y)21.51%
ROIC(3y)15.18%
ROIC(5y)16.08%
1.3 Margins
EQS has a Profit Margin of 16.72%. This is amongst the best in the industry. EQS outperforms 90.91% of its industry peers.
EQS's Profit Margin has been stable in the last couple of years.
EQS has a better Operating Margin (20.18%) than 100.00% of its industry peers.
In the last couple of years the Operating Margin of EQS has declined.
EQS's Gross Margin of 68.77% is on the low side compared to the rest of the industry. EQS is outperformed by 63.64% of its industry peers.
In the last couple of years the Gross Margin of EQS has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 20.18% | ||
| PM (TTM) | 16.72% | ||
| GM | 68.77% |
OM growth 3Y-8.16%
OM growth 5Y-4.74%
PM growth 3Y-6.19%
PM growth 5Y-1.37%
GM growth 3Y-0.25%
GM growth 5Y0.16%
2. Health
2.1 Basic Checks
EQS has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
EQS has about the same amout of shares outstanding than it did 1 year ago.
Compared to 5 years ago, EQS has more shares outstanding
EQS has a better debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 4.54 indicates that EQS is not in any danger for bankruptcy at the moment.
EQS has a Altman-Z score of 4.54. This is amongst the best in the industry. EQS outperforms 90.91% of its industry peers.
EQS has a debt to FCF ratio of 1.29. This is a very positive value and a sign of high solvency as it would only need 1.29 years to pay back of all of its debts.
With a decent Debt to FCF ratio value of 1.29, EQS is doing good in the industry, outperforming 72.73% of the companies in the same industry.
EQS has a Debt/Equity ratio of 0.12. This is a healthy value indicating a solid balance between debt and equity.
With a decent Debt to Equity ratio value of 0.12, EQS is doing good in the industry, outperforming 72.73% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.12 | ||
| Debt/FCF | 1.29 | ||
| Altman-Z | 4.54 |
ROIC/WACC1.57
WACC7.67%
2.3 Liquidity
A Current Ratio of 1.21 indicates that EQS should not have too much problems paying its short term obligations.
EQS has a Current ratio (1.21) which is in line with its industry peers.
EQS has a Quick Ratio of 1.10. This is a normal value and indicates that EQS is financially healthy and should not expect problems in meeting its short term obligations.
EQS has a Quick ratio (1.10) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.21 | ||
| Quick Ratio | 1.1 |
3. Growth
3.1 Past
The earnings per share for EQS have decreased strongly by -23.02% in the last year.
Measured over the past 5 years, EQS shows a small growth in Earnings Per Share. The EPS has been growing by 5.12% on average per year.
EQS shows a decrease in Revenue. In the last year, the revenue decreased by -1.37%.
The Revenue has been growing slightly by 6.45% on average over the past years.
EPS 1Y (TTM)-23.02%
EPS 3Y-2.55%
EPS 5Y5.12%
EPS Q2Q%-24.02%
Revenue 1Y (TTM)-1.37%
Revenue growth 3Y3.93%
Revenue growth 5Y6.45%
Sales Q2Q%1.49%
3.2 Future
The Earnings Per Share is expected to grow by 18.54% on average over the next years. This is quite good.
Based on estimates for the next years, EQS will show a small growth in Revenue. The Revenue will grow by 7.74% on average per year.
EPS Next Y27.31%
EPS Next 2Y18.54%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year9.26%
Revenue Next 2Y11.8%
Revenue Next 3Y9.29%
Revenue Next 5Y7.74%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 21.05 indicates a rather expensive valuation of EQS.
Based on the Price/Earnings ratio, EQS is valued cheaper than 90.91% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 26.17, EQS is valued at the same level.
Based on the Price/Forward Earnings ratio of 17.23, the valuation of EQS can be described as rather expensive.
EQS's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. EQS is cheaper than 63.64% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.10, EQS is valued a bit cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 21.05 | ||
| Fwd PE | 17.23 |
4.2 Price Multiples
EQS's Enterprise Value to EBITDA ratio is in line with the industry average.
Based on the Price/Free Cash Flow ratio, EQS is valued a bit cheaper than 63.64% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 21.25 | ||
| EV/EBITDA | 12.43 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of EQS may justify a higher PE ratio.
EQS's earnings are expected to grow with 18.54% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.77
PEG (5Y)4.11
EPS Next 2Y18.54%
EPS Next 3YN/A
5. Dividend
5.1 Amount
EQS has a Yearly Dividend Yield of 2.46%.
EQS's Dividend Yield is a higher than the industry average which is at 3.69.
Compared to an average S&P500 Dividend Yield of 2.40, EQS has a dividend comparable with the average S&P500 company.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.46% |
5.2 History
On average, the dividend of EQS grows each year by 8.00%, which is quite nice.
Dividend Growth(5Y)8%
Div Incr Years1
Div Non Decr Years1
5.3 Sustainability
EQS pays out 51.86% of its income as dividend. This is a bit on the high side, but may be sustainable.
The dividend of EQS is growing, but earnings are growing more, so the dividend growth is sustainable.
DP51.86%
EPS Next 2Y18.54%
EPS Next 3YN/A
EPA:EQS (5/29/2025, 2:15:02 PM)
50.3
+0.3 (+0.6%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners13.44%
Inst Owner ChangeN/A
Ins Owners0.2%
Ins Owner ChangeN/A
Market Cap763.05M
Analysts76.67
Price Target60.69 (20.66%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.46% |
Yearly Dividend1.25
Dividend Growth(5Y)8%
DP51.86%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-14.57%
PT rev (3m)-14.57%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-2.36%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 21.05 | ||
| Fwd PE | 17.23 | ||
| P/S | 3.52 | ||
| P/FCF | 21.25 | ||
| P/OCF | 16.05 | ||
| P/B | 3.3 | ||
| P/tB | 9.35 | ||
| EV/EBITDA | 12.43 |
EPS(TTM)2.39
EY4.75%
EPS(NY)2.92
Fwd EY5.8%
FCF(TTM)2.37
FCFY4.71%
OCF(TTM)3.13
OCFY6.23%
SpS14.29
BVpS15.26
TBVpS5.38
PEG (NY)0.77
PEG (5Y)4.11
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 9.1% | ||
| ROE | 15.65% | ||
| ROCE | 14.76% | ||
| ROIC | 12.02% | ||
| ROICexc | 14.31% | ||
| ROICexgc | 35.95% | ||
| OM | 20.18% | ||
| PM (TTM) | 16.72% | ||
| GM | 68.77% | ||
| FCFM | 16.57% |
ROA(3y)11.42%
ROA(5y)11.3%
ROE(3y)20.52%
ROE(5y)21.51%
ROIC(3y)15.18%
ROIC(5y)16.08%
ROICexc(3y)19.36%
ROICexc(5y)21.38%
ROICexgc(3y)50.59%
ROICexgc(5y)62.81%
ROCE(3y)18.64%
ROCE(5y)19.75%
ROICexcg growth 3Y-25.09%
ROICexcg growth 5Y-9.54%
ROICexc growth 3Y-15.77%
ROICexc growth 5Y-10.18%
OM growth 3Y-8.16%
OM growth 5Y-4.74%
PM growth 3Y-6.19%
PM growth 5Y-1.37%
GM growth 3Y-0.25%
GM growth 5Y0.16%
F-Score5
Asset Turnover0.54
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.12 | ||
| Debt/FCF | 1.29 | ||
| Debt/EBITDA | 0.48 | ||
| Cap/Depr | 79.39% | ||
| Cap/Sales | 5.37% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 81.41% | ||
| Profit Quality | 99.11% | ||
| Current Ratio | 1.21 | ||
| Quick Ratio | 1.1 | ||
| Altman-Z | 4.54 |
F-Score5
WACC7.67%
ROIC/WACC1.57
Cap/Depr(3y)96.13%
Cap/Depr(5y)118.08%
Cap/Sales(3y)6.18%
Cap/Sales(5y)7.08%
Profit Quality(3y)94.47%
Profit Quality(5y)93.6%
High Growth Momentum
Growth
EPS 1Y (TTM)-23.02%
EPS 3Y-2.55%
EPS 5Y5.12%
EPS Q2Q%-24.02%
EPS Next Y27.31%
EPS Next 2Y18.54%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-1.37%
Revenue growth 3Y3.93%
Revenue growth 5Y6.45%
Sales Q2Q%1.49%
Revenue Next Year9.26%
Revenue Next 2Y11.8%
Revenue Next 3Y9.29%
Revenue Next 5Y7.74%
EBIT growth 1Y-20.84%
EBIT growth 3Y-4.55%
EBIT growth 5Y1.4%
EBIT Next Year71.53%
EBIT Next 3Y25.63%
EBIT Next 5YN/A
FCF growth 1Y-8.64%
FCF growth 3Y-1.08%
FCF growth 5Y8.7%
OCF growth 1Y-17.61%
OCF growth 3Y0.02%
OCF growth 5Y3.18%